News Highlights

May 14, 2012
Maxygen To Receive $30 Million Payment from Bayer

May 7, 2012
Maxygen Reports First Quarter 2012 Financial Results

March 8, 2012
Maxygen Reports Fourth Quarter and Year End 2011 Financial Results

January 10, 2012
Maxygen Announces $10 Million Stock Repurchase Program

November 9, 2011
Maxygen Announces BARDA Decision Not To Award Contract for Development of MAXY-G34 for Acute Radiation Syndrome